Monoclonal Antibodies in Aggressive NHL

" Than. Survival. A pretty low -- is about a year. So operation do well but they never created a problem. Never being free or low grade or insulin -- means the disease is likely to recur requiring additional rounds of treatment. Standard options. And who have relapsed and -- Omaha include many seemed in their -- that initial treatment. The challenge is that they tend to be active. The second third -- and then they are the first time. In 1990 it in a different type of drug called monoclonal antibody was approved an alternative treatment recurrent -- lymphoma. "

" And is a lot and yes and -- about dean add an -- treatment -- that effective. Aunt what eighth. That didn't -- the difference. -- and compared. To scare me. I truthful one exit exit different formats there -- Sell it differently that polls and still we're no longer is it unfair. -- And perhaps even more important thing I had very little eight. The treatment couldn't ask. You read. It with her current. Prominent me talk city is associated retreated to hear that you would not they're."

" The initial study on older patience with -- you know. -- similar results for patients treated with the second round of chemotherapy. Those results showed that about fifty to 60%. Of relapse in the little home -- response -- in. Are there to. Bordeaux. Treatment afford doses -- and in general those are -- and in the range about it."

" They've never admit that it is. Broccoli. Equal to that being what combination therapy. It's important to note that the likelihood of response duration of response. Highly variable. And depends upon individual. Patient character -- and they're his."

" Do you have monoclonal antibody against recurrence in -- to see can be alone or in combination with chemotherapy. The choice often depends on how quickly -- and might need to respond."

" Well we haven't learned over the years between the pendulum. Is harmony there. You're really eat indicated or in a situation where it hasn't recurrence. It asks. Is in the category of a large Matta to eat and orders -- to -- quickly and cost. And anywhere -- hasn't and in the -- low number of our. Apartment. Is where. Directly. We have perhaps -- But the end of our current management habits and that -- and -- off or alt."

" Several treatment options are available for patients with recurrent -- and non hodgkin's lymphoma. But in treating recurrent disease is often more difficult initial treatment. Doctors welcome each new -- and in a scenario. You are not responding to a specific form of treatment -- So -- different type of treatment and body being treatment. Can be helpful and provide them -- and -- And I are empty and have he's not responding to an antibody that type that in chemotherapy may be. So. I think the more drugs we have -- effective. The more options we have. Ten to being able to use when other things aren't working as."